ranimustine has been researched along with Ependymoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bando, K; Kannuki, S; Kuroda, Y; Matsumoto, K; Shirakawa, N; Takaue, Y | 1 |
| Kurihara, H; Miyazaki, M; Ohye, C; Ono, N; Tamura, M | 1 |
2 other study(ies) available for ranimustine and Ependymoma
| Article | Year |
|---|---|
[Intensive and high-dose chemotherapy with peripheral blood stem cell transfusion for pediatric malignant brain tumor].
Topics: Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Ependymoma; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Nitrosourea Compounds; Pinealoma | 1995 |
Adjunctive treatment for recurrent childhood ependymoma of the IV ventricle: chemotherapy with CDDP and MCNU.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cerebral Ventricle Neoplasms; Child; Child, Preschool; Cisplatin; Drug Administration Schedule; Ependymoma; Female; Follow-Up Studies; Humans; Male; Nitrosourea Compounds; Recurrence; Tomography, X-Ray Computed | 1990 |